Innovators are Greg Batcheller, Thomas Hedner, Werner Schubert, Jörgen Johnsson, Olov Sterner, Christer Sjögren and Malgorzata Sznitowska.


Greg Batcheller

B.Sc. (Econ), J.D, LL.M. Chairman of Xintela AB, Monocl AB, Saga Diagnostics AB, ImmuneBiotech Medical AB and CarryGenes Therapeutics AB. Partner of Business Research Life Sciences Ltd. Advisor to pharmaceutical, biotech, medical device and other high technology companies. Former Project Leader of DuoCort AB and AcuCort AB. 


Thomas Hedner

MD, PhD (Medicine and Economics), Professor in Clinical Pharmacology at the Department of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. MBA and Econ Dr from Linköping University. Author of more than 600 scientific publications. Innovator and entrepreneur in multiple start-up companies, including several Aqilion project companies.

Jörgen Johnsson 

Studies in business administration and marketing corresponding to an MBA. During the years 1979 - 2000 he held several international and leading positions in Swedish pharmaceutical companies and he actively participated in the development and transformation of the industry throughout the 1980s and 1990s. After Pharmacia's acquisition of Upjohn Company, Pharmacia Corporation was formed. He was then CEO of the Group's Consumer Drugs Division, Consumer Healthcare Worldwide. He was also Senior Vice President of Pharmacia Corporation and a member of the Group's operational management team until he chose to leave the industry for other interests in 2000. He is the founder of AQILION AB and innovator in multiple Aqilion project companies.


Christer Sjögren

DVM, PhD, former consulting professor in Experimental Obstetrics and Gynecology at Uppsala University, Associate Professor in Pharmacology at the Veterinary Faculty of SLU (Swedish University of Agricultural Sciences). Former research director at Pharmacia, Perstorp, Novo Nordisk, Head of Clinical Operations at Quintiles, Vice President at CDC, Director at the Centre for Research on Pharmaceuticals at Lund University, Sweden, and board member of Vinnova's (Sweden's innovation agency) national program for pharmaceuticals, biotechnology and medical technology. Member of the Board of Peptonic AB, 2009 -2012. Chairman of the Board and co-founder of SWIPP AB, 2017. 




Werner Schubert

MD and has since 1983 been a specialist in obstetrics and gynecology. PhD 1995 from University of Gothenburg, Sweden.
Dr Schubert is running a private practice in gynecology in Gothenburg.



Olov Sterner

M.Sc, PhD, Professor in Organic Chemistry, Faculty of Science, Lund University, Sweden. Major research fields are biologically active secondary metabolites and medicinal chemistry. Author or co-author of more than 420 publications in scientific journals, 30 patents/patent applications, and five text books in organic chemistry/chemical toxicology. Board member of Glactone Pharma AB. Innovator in multiple Aqilion project companies.


Malgorzata Sznitowska 

Professor and Head of Pharmaceutical Technology at the Medical University of Gdansk, Poland. She is the author of numerous scientific papers and several books/papers in the area of galenics and with experienced co-workers and very good laboratory infrastructure she runs many projects in galenic technologies. She is a member of the Polish Pharmacopoeia Commission and collaborates with the Polish Medicinal Products Regulatory Authority. She has worked on product development for the pharma industry related to injections, eye-drops, topical preparations (ointments, adhesives), tablets, etc.








Recently Updated

Laccure ends collaboration…

PRESS RELEASE Helsingborg, Sweden, February 12, 2019 Combe...

Laccure AB and…

PRESS RELEASE Laccure AB, a Swedish development company,...

Recipharm and Laccure…

Leading contract development and manufacturing organisation (CDMO)...

Recipharm och Laccure…

Recipharm, ett ledande CDMO-företag (Contract Development and...



Translate this site with Google

English French German Italian Russian Spanish Swedish